Table 1.

Intracranial meningiomas

ID	Age (y)	Sex	WHO Grade	Lesion with Histology	Time between MRI Scans (mo)	Initial Volume (mm3)	Growth Rate (%)	SUVmax (g/mL)
1	42.0	Male	I	x	16	5726	14.58	22
						3107	15.51	26.1
						460	8.92	8.6
						431	22.88	32
2a	29.6	Female	I/II		10	2561	1.87	6.3
			I/II			2312	3.77	6.8
			II	x		1689	21.51	19.1
			I/II			952	13.79	10
			I/II			795	7.51	6
3b	44.3	Female	I		11	759	10.47	10.9
						544	13.67	15.1
						483	11.09	11.7
4	68.2	Male	I		11	4142	14.71	14.9
						435	13.58	11.1
				x		345	10.58	10.7
				x		251	4.26	6
5	49.7	Female	I		8	1841	12.76	16
				x		1054	18.38	18.8
						748	26.05	20.2
						483	16.40	15.9
						460	29.76	24
6	45.2	Female	I	x	5	8186	4.33	9.3
7	42.5	Female	II	x	6	483	4.91	4.8
						408	18.81	14.3
8	73.4	Female	II		12	259	6.05	3.3
						157	6.92	4.6
				x		146	6.20	5.6
						94	6.50	4.5
9	62.0	Female	II		13	314	8.09	9.7
				x		167	4.53	6
10	37.2	Male	II		20	1849	0.82	3
						1657	28.81	17.4
				x		598	1.24	3.2
						366	0.81	2.6
						362	1.16	3.5
11	28.4	Female	II	x	13	226	2.96	3.8
				x		176	4.04	4.2
						75	4.48	5
12	7.0	Male	II	x	10	925	2.12	4.7
13	63.1	Female	II	x	7	1255	7.08	7.5
14	68.1	Female	II	x	6	316	1.83	7.1
						774	18.18	12.9
15	52.2	Female	II		12	10 632	3.38	22
						1245	2.24	20.9
				x		322	2.57	8
16	75.1	Male	II		10	2457	10.72	14
				x		1809	3.18	7.6
17	64.5	Female	II	x	11	63	0.16	2.9
18c	68.7	Male	II		5	264	23.96	18.9
						188	13.91	15.7

^aPatient with ID #2 had meningiomas with WHO grades I and II in histology (intracranial and transosseous); therefore, meningiomas without biopsy were not allocated to a specific WHO grade (as indicated by “I/II”).

^bPatient with ID #3 had intracranial and transosseous meningiomas; the latter was operated on and histology was obtained.

^cPatient with ID #18 received total resection of another meningioma from which histology was obtained.